Finalist
Collaborate, Educate, Innovate: Amplifying the Patient Voice in HER2-Mutant Metastatic Non-Small Cell Lung cancer (mNSCLC) Care
by HCG on behalf of Boehringer Ingelheim
Summary of work
For too long, delayed diagnosis and a lack of treatment options have left patients with HER2mutant mNSCLC feeling frustrated and unheard. To better understand the patient experience, Boehringer Ingelheim took a novel approach to the inaugural HER2 Summit. The 2day event brought together a crossfunctional group of oncologists, nurses, pharmacists, pathologists, patient organisations and, most importantly, patients and their care partners participating in shared conversation. Mixed specialty breakout groups learned about the patient experience firsthand and discussed new educational approaches and resources for healthcare professionals and patients. Attendees interacted with stateofthe art technology, from augmented reality experiences that could transform the way physicians and patients learn about HER2mutant mNSCLC to holographic presentations that transported people onto the same stage. Perspectives usually expressed alone were part of real-time collaborative discussions, laser-focused on educational needs, improving support and optimising patient care. This unique experience was a success, with several outputs developed that could evolve education and the way physicians and patients interact with each other to make treatment decisions. With a follow-up summit planned for 2026, the HER2 summit embodies Boehringer’s unwavering commitment to patients with HER2mutant mNSCLC and reminds us of what’s possible when every voice is heard.
Judges’ comments
The implementation for ‘Collaborate, Educate, Innovate’ had a good focus on multidisciplinary engagement, over a wide variety of formats. The judges really liked the patient centricity of this programme and multi-stakeholder approach. It is an innovative method successfully overcoming compliance challenges to bring patients and HCPs together to discuss challenges and proposed solutions to improving patient care. Overall, the outcomes achieved what they intended to.
